Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalk

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514573, 514724, 514913, A61K 31215, A61K 3119, A61K 31045

Patent

active

054865409

ABSTRACT:
The present invention provides therapeutic agents comprising cyclopentane heptane or heptenoic acid, 2 arylalkyl or arylalkenyl and derivatives thereof, wherein the carboxylic acid of the parent compound is converted to a hydroxyl or ester group. These therapeutic agents are potent ocular hypotensives as well as having other therapeutic uses.

REFERENCES:
patent: 4494274 (1991-02-01), Chan et al.
patent: 4599353 (1991-07-01), Bito
patent: 5034413 (1991-07-01), Chan et al.
Caton et al, "Synthesis of Some Novel 11-Deoxyprostaglandins", Chemistry, Biochemistry & Pharmacological Activity of Prostanoids, 1978, pp. 27-38.
Chemical Abstracts, vol. 90, Columbus, Ohio, No. 103514h 1979.
Chemical Abstracts, vol. 90, Columbus, Ohio, No. 103508j 1979.
Bito, L. Z., "Prostaglandins and Related Compunds as Potential Ocular Therapeutic Agents," Biological Protection with Prostaglandins, Cohen, M. M., ed., Boca Raton, Fla., CRC Press, Inc., 1985, pp. 231-252.
Bito, L. Z., "Prostaglandins, Other Eicosanoids, and Their Derivatives as Potential Antiglaucoma Agents," Applied Pharmacology in the Medical Treatment of Glaucomas Drance, S. M. and Neufeld, A. H. eds., New York, Grune & Stratton, 1984, pp. 477-505.
Nilsson, et al., "PGF.sub.2.alpha. Increases Uveoscleral Outflow," Invest. Ophthalmol. Vis. Sci. (suppl), 284, 1987.
Siebold, et. al., "Esterified prostaglandin shows `potent` promise," Prodrug 53, 1989.
Bito, L. Z., "Prostaglandins, Old Concepts and New Perspectives," Arch. Ophthalmol. 105, 1036, 1987.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalk does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalk, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalk will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1505317

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.